The global disposable infusion bag market is poised for significant growth from 2025 to 2030, driven by increasing demand for safe and efficient drug delivery systems. Disposable infusion bags are widely used in hospitals, clinics, and other healthcare settings for intravenous therapy, ensuring sterility and reducing the risk of contamination. The market is expected to grow at a CAGR of 5.2% to 6.8% during the forecast period, reaching a valuation of approximately $4.5 billion to $5.2 billion by 2030.
In 2025, the disposable infusion bag market is projected to be valued at around $3.8 billion. By product type, flex plastic IV bags dominate the market, accounting for 45%-50% of the total share due to their lightweight, cost-effectiveness, and ease of use. Semi-rigid IV bags hold a 30%-35% share, while glass bottles represent a smaller segment at 10%-15% due to their higher cost and fragility.
The market is highly competitive, with key players such as Baxter, SSY Group, B.Braun, Fresenius Kabi, and Pfizer leading the industry. These companies collectively hold 60%-65% of the market share. Other notable players include Otsuka, Cisen Pharmaceutical, Renolit, Technoflex, Huaren Pharmaceutical, CR Double-Crane, ICU Medical, Pharmaceutical Solutions Industry Ltd, Vioser, Sippex, Well Pharma, and Zhejiang CHIMIN.
The disposable infusion bag market is witnessing several key trends:
Recent developments in the disposable infusion bag market include:
The disposable infusion bag market is expected to witness steady growth across all segments:
The global disposable infusion bag market is set for robust growth from 2025 to 2030, driven by increasing healthcare demand, technological advancements, and regulatory support. With key players focusing on innovation and sustainability, the market is expected to offer lucrative opportunities for stakeholders across regions and segments.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook